Atlas Trials

Clinical Study of Mitoxantrone Liposome and Azacitidine in the Treatment of R/R AITL

Clinical trial NCT06224842 · UNKNOWN

Trial details

NCT number
NCT06224842
Sponsor
Huijing Wu
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Angioimmunoblastic T-cell Lymphoma
Start date
2023-12-12
Primary completion
2024-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.